Proteus mirabilis expresses different types of fimbriae simultaneously. Several fimbrial types have been described and their role in the colonization of the urinary tract is under study. Previously, P. mirabilis fimbriae (PMF) have been shown to be associated with bacterial colonization of the lower urinary tract but not of the kidneys. In this study, a pmfA mutant was generated and used in several in vivo and in vitro studies. Two different urinary tract infection models in the mouse and two in vitro assays of bacterial adhesion to uroepithelial cells were performed. Expression of PmfA in a collection of P. mirabilis strains of different sources was also assessed. The results shown here indicate that PMF are involved in both bladder and kidney colonization by P. mirabilis and that these fimbriae are widely distributed among P. mirabilis isolates from different origins since all strains tested expressed PmfA.
INTRODUCTION
Proteus mirabilis is an important cause of a variety of opportunistic and nosocomial infections in humans (Stamm et al., 1977) . Although P. mirabilis does not commonly cause urinary tract infections (UTIs) in the normal host, it can cause severe UTIs particularly in patients with urinary catheters or in people with structural abnormalities of the urinary tract (Warren et al., 1982) . The organism shows a predilection for the upper urinary tract where it can contribute to renal damage and can frequently cause complications, such as stone formation in the kidneys and bladder, and bacteraemia (Mobley & Hausinger, 1989; Senior, 1979) .
Virulence of P. mirabilis has been related to several potential factors including swarming motility mediated by flagella, urease production, cell invasiveness, haemolysin production, cleavage of IgA and IgG by proteolytic enzymes, lipopolysaccharide, capsular polysaccharide, resistance to normal serum, outer-membrane proteins, binding of environmental iron and adherence to the uroepithelium due to fimbriae (Rozalski et al., 1997) . This last factor is thought to be one of the most important virulence properties of uropathogenic bacteria. P. mirabilis represents a particular case in which various types of fimbriae can be expressed simultaneously by the same cell (Mobley & Belas, 1995) . The different fimbriae include mannose-resistant Proteus-like haemagglutinin (MR/P), P. mirabilis fimbriae (PMF), uroepithelial cell adhesin (UCA) and ambient-temperature fimbriae (ATF). suggested that PMF could have a role in the colonization of the bladder but not in the colonization of kidney tissue. also described the pmf gene cluster, encoded by 5655 bp that predicted five polypeptides: PmfA, PmfC, PmfD, PmfE and PmfF. They determined that the pmf operon shares features with fimbrial gene clusters from enteric bacteria but that it also displays features that are unique.
The purpose of the present study was to assess the role of PMF in UTIs using different experimental approaches. An isogenic pmfA mutant was generated and characterized, and used in a co-infection ascending UTI model and a haematogenous UTI model in the mouse. It was also used in different tests to evaluate in vitro bacterial adherence to uroepithelial cells. Expression of PmfA was determined in numerous P. mirabilis strains isolated from different origins.
METHODS
Bacterial strains and plasmids. P. mirabilis strains used in this study are listed in Table 1 . Escherichia coli XL-1Blue was used for initial cloning of the DNA into plasmid vectors and for maintenance of the plasmids (Bullock et al., 1987) . For conjugation experiments, E. coli SM10lpir was used as a donor (Simon et al., 1983) . The l lysogen E. coli BL21(lDE3) was used for overexpression of PmfA IP: 54.70.40.11
On: Tue, 18 Dec 2018 07:08:08 (Studier & Moffatt, 1986) . pUC19 was used for routine cloning. The kanamycin-resistance (Km R ) cassette used for the generation of the pmfA mutant was obtained from pUC4K (Vieira & Messing, 1982) . pCVD442 was used in conjugation experiments (Donnenberg & Kaper, 1991) . This plasmid depends on ori6K for replication initiation, so it only replicates in the presence of the p protein, encoded by pir. In the absence of pir, pCVD442 cannot replicate and behaves as a suicide plasmid. pCVD442 contains the sacB gene, which provides a counter-selection against vector survival, since growth on sucrose in the presence of the sacB gene is lethal. For PmfA protein expression, pET-21a(+) was used (Studier & Moffatt, 1986 ).
Media and reagents. All media components were from Difco Laboratories and all chemicals were reagent grade (Sigma). Restriction and DNA-modifying enzymes were purchased from Boehringer Mannheim.
PCR and DNA sequencing. PCR using chromosomal DNA from Pr2921 as template was performed to amplify the DNA flanking pmfA for allelic replacement mutagenesis. Primers used for the PCR were derived from the published pmf fimbrial operon sequence from strain HI4320, GenBank accession number Z35428 . Primers 59pm1 (59-CAAATTAATCTAGAACCA-CTC-39) and 39pm1 (59-ATTATAGAGGATCCCTTGAAGGTA-39), spanning positions 2212-2232 and 2806-2829 of the published sequence, respectively, were used to amplify a 59 pmfA DNA fragment (pm1). The cycle used was 94 uC for 2 min, followed by 30 cycles of 94 uC for 1 min, 54 uC for 1 min and 72 uC for 1 min, with a final cycle at 72 uC for 5 min.
Primers 59pm2 (59-TCAAGCTGGATCCGCTGACGCTAAAG-39) and 39pm2 (59-AGGGTCGATGCATGCCACGGAATGAT-39), spanning positions 3304-3329 and 3822-3847 of the published sequence, respectively, were used to amplify a DNA fragment (pm2) that corresponds to the 59 end of pmfC, the putative molecular usher of PMF, which is the first gene downstream of pmfA in the PMF operon. The cycle used was 94 uC for 2 min, followed by 30 cycles of 94 uC for 1 min, 58 uC for 1 min and 72 uC for 1 min, with a final cycle at 72 uC for 5 min.
PCR was also performed to amplify pmfA for cloning into pET21a(+), using Pr2921 chromosomal DNA as template. In order to facilitate protein expression, the amplified DNA fragment did not include the leader peptide sequence. The 39-end oligonucleotide carried a C-terminal fusion of six histidine (His 6 ) residues to enable one-step purification of the expressed protein using Nickel-agarose columns. The 59-end and 39-end primers were 59-TCTGTTG-CTCATATGGAAAATGAAACGCCT-39 and 59-TCAATAAGCTTA-ATGGTGATGGTGATGGTGCTGATAATCAACTTG-39, respectively. NdeI and HindIII restriction sites were incorporated into the 59 and 39 primers, respectively, for cloning procedures. The cycle used was 94 uC for 3 min, followed by 30 cycles of 94 uC for 1 min, 40 uC for 1 min and 72 uC for 1 min, with a final cycle of 72 uC for 5 min.
DNA sequencing was performed at the Department of Biochemistry, University of Cambridge, using an Applied Biosystems automated DNA sequencer (model 377). DNA sequences from the cloned genes were compared to published sequences using the BLASTn search tool (Altschul et al., 1990) . Oligonucleotides for DNA sequencing (Genosys) in pET-21a(+) were 59-TAATACGACTCACTATAG-39 (forward primer) and 59-GCTAGTTATTGCTCAGCG-39 (reverse primer).
Mutagenesis of pmfA in P. mirabilis. The pmfA isogenic mutant of P. mirabilis, P2, was constructed by conjugating Pr2921 (wild-type) with E. coli SM10lpir (pCVD442pmfA : : km) as described previously (Legnani-Fajardo et al., 1996) . After conjugation, bacteria were scraped from the plates, suspended in PBS and plated again at various dilutions on Luria-Bertani (LB) agar lacking NaCl and solidified with 2 % (w/v) agar to inhibit any swarming and containing kanamycin (40 mg ml 21 ), tetracycline (10 mg ml 21 ) and sucrose (10 %, w/v). Pr2921 is naturally resistant to tetracycline, which was used to counter-select the E. coli donor strain.
Southern blotting. Southern blots were prepared by standard procedures as described previously (Zunino et al., 2000) . The probe DNA was labelled with [a- Then, the membrane was air-dried and exposed to X-ray film (X-Omat LS; Kodak).
Overexpression and purification of PmfA-His 6 fusion protein.
pmfA lacking its N-terminal signal peptide sequence was amplified by PCR for cloning into pET-21a(+). After digestion with NdeI and HindIII, the DNA fragments were ligated into NdeI/HindIII-digested pET-21a(+). The ligation was transformed into E. coli XL-1Blue. Then, the pET-21a(+) construct containing pmfA was moved into the l lysogen E. coli BL21(lDE3) by transformation, for expression of recombinant PmfA. Overexpression and purification of PmfA were performed according to instructions provided by the manufacturer (Novagen; pET System Manual, 6th edn, 1985) as described previously (Pellegrino et al., 2003) . The protein concentration was determined by the Lowry method using BSA as a standard.
Antiserum preparation. The immune serum was prepared by immunization of a New Zealand White rabbit using a four-dose schedule. All doses contained 100 mg of purified PmfA. The first dose was emulsified in Freund's complete adjuvant (Sigma), then the three subsequent doses were given at 2 week intervals in Freund's incomplete adjuvant (Sigma). Serum was collected 1 week after the last immunization and pre-adsorbed with P. mirabilis pmfA mutant to reduce non-specific reactions (Gruber & Zingales, 1995) .
SDS-PAGE and Western blot. Proteins and whole bacteria were suspended in sample buffer and boiled for 5 min before loading onto 15 % (w/v) SDS-polyacrylamide gels. The gels were prepared and run according to Sambrook et al. (1989) . For Western blot assays, proteins were transferred from SDS-polyacrylamide gels to nitrocellulose membranes (Bio-Rad), according to Sambrook et al. (1989) . Western blots were developed using a 1/200 dilution of a rabbit polyclonal immune antiserum raised against purified recombinant PmfA.
Animals and infection models. Female CD-1 mice weighing 20-25 g from the breeding facilities at IIBCE were used and provided with food pellets and tap water as necessary. All animal experiments were conducted in accordance with procedures authorized by IIBCE, Montevideo, Uruguay. To assess the virulence of the wildtype and the pmfA mutant strains, two mouse models of UTI were used.
Initially, a co-challenge experiment was performed in the ascending UTI model described previously (Zunino et al., 2000) . Sixteen mice were challenged with 0?05 ml of a bacterial suspension in PBS containing 10 8 colony-forming units (c.f.u.) of Pr2921 and 10 8 c.f.u. of the pmfA mutant. Seven days after inoculation, mice were killed by cervical dislocation. Kidneys and bladders were removed aseptically and homogenized in 10 ml of PBS using a Stomacher 80 Lab Blender (Seward). Viable bacterial counts were done on LB with 2 % (w/v) agar and without NaCl to avoid swarming motility. LB agar and LB agar supplemented with kanamycin (40 mg ml 21 ) were used for differential bacterial counts. When the haematogenous model was used (Peerbooms et al., 1982) , bacterial suspensions in PBS (0?1 ml), at a concentration of 10 7 c.f.u., were injected into a tail vein. Seven days after infection, mice were killed by cervical dislocation, and the presence of bacteria in the kidneys was assessed by direct sampling on LB agar.
Adherence to uroepithelial cells. This was investigated using two different in vitro assays. First, T24/83 cells, derived from an original human bladder carcinoma T24 cell line, were used (European Collection of Cell Cultures; ECAC ref. no. 85061107) (Tolson et al., 1997) . For the adherence assay, bacteria from an 18 h culture at 37 uC on LB agar were inoculated into 5 ml of LB broth and grown statically at 37 uC for 48 h. Then, bacteria were harvested and resuspended in McCoy's 5a supplemented with 2 mM glutamine and 10 % (v/v) fetal calf serum to 2610 8 c.f.u. ml 21 . Next, the medium from the wells was aspirated, each well was inoculated with 1 ml of the bacterial suspensions and the plates were incubated at 37 uC, 5 % CO 2 . After 1 h, cells were washed five times with PBS to remove unattached bacteria. After the last wash, 1 ml of 0?5 % (v/v) PBS/ Triton X-100 was added per well and incubated for 15 min under the same conditions to lyse eukaryotic cells. Experiments were performed in triplicate. The number of remaining attached bacteria was determined by viable plate counts.
Second, uroepithelial cells from fresh urine of healthy female volunteers were used. In this case, the assay was performed following a modified method described by Wray et al. (1986) . Uroepithelial cells were isolated from the urine of three healthy female volunteers by centrifugation at 400 g for 10 min, then washed three times in buffered saline with gelatin [BSG; containing 0?15 M NaCl, 0?004 M potassium phosphate, pH 6?0, and 0?1 % (w/w) gelatin] and pellets were resuspended in BSG at 5610 5 cells ml
21
. The cell suspensions were mixed with an equal volume of a bacterial suspension containing 10 9 c.f.u. ml 21 and incubated for 1 h at 37 uC. Then, cells were washed four times in BSG, smears were prepared for light microscopy and bacteria attached to 50 uroepithelial cells were counted.
Other assays for phenotypic characterization of the pmfA mutant. Pr2921 and the isogenic pmfA mutant P2 were tested for a variety of phenotypes, including swarming motility, growth rate, haemagglutination, and urease and haemolysin production as described previously (Zunino et al., 2001; Legnani-Fajardo et al., 1996) . Both strains were also co-cultured in LB broth at 37 uC for 7 days to assess the mutant fitness in vitro. Then, bacteria were plated on LB with 2 % (w/v) agar and without NaCl to avoid swarming motility and LB agar supplemented with kanamycin (40 mg ml 21 ); these media were used for differential bacterial counts.
Statistical analysis. Mann-Whitney one-tailed non-parametric analysis was used to compare bacterial colonization levels in kidneys and bladders. The chi-square test with Yates correction for small sample sizes was used to compare the numbers of animals infected with the parental and mutant bacteria. To analyse the results of the experiments to determine bacterial adherence to uroepithelial cells, the Student's t-test was used. P<0?05 was considered significant.
RESULTS

pmfA mutagenesis
The 59pm1 and 39pm1 oligonucleotides amplified a 618 bp DNA product (pm1), spanning positions 2212-2829 of the published pmfA sequence, and the 59pm2 and 39pm2 oligonucleotide pair amplified a DNA product of 544 bp (pm2), spanning positions 3304-3847. The pmf PCR products were digested (pm1 with XbaI and BamHI, and pm2 with SphI and BamHI) and then ligated in a four-way ligation with XbaI/SphI pre-digested pUC19 as well as the Km R gene cassette, digested with BamHI. On transformation of this ligation into E. coli XL-1Blue, with subsequent selection on kanamycin and ampicillin, the plasmid generated consisted of the Km R cassette cloned between the pmfA flanking regions. This construct was subjected to a XbaI/SphI double digestion that released an insert of about 2?4 kb. This insert was subcloned into the suicide vector pCVD442 and transformed into E. coli SM10lpir. The P. mirabilis pmfA mutants were constructed by conjugating Pr2921 (wild-type) with the resulting E. coli SM10lpir(pCVD442pmfA : : km) strain. Putative transconjugant colonies were streaked out onto sucrose/kanamycin/ tetracycline or ampicillin plates. Two clones, P1 and P2, which were Suc R /Km R /Tet R /Amp S and showed the characteristic Proteus swarming motility when grown on LB agar plates, were selected for further study.
Genetic analysis of the pmfA mutant
Appropriate genomic rearrangements were checked by Southern hybridization. Initially, DNA isolated from wildtype and mutant strains was digested with HindIII and SspI, separately, and probed with pmfA amplified by PCR. This probe hybridized with the restriction digest bands predicted from the published sequence. The Pr2921 DNA bands, generated with SspI (0?9 kb) and HindIII (1?2 kb), hybridized with the pmfA probe as expected. P1 and P2 did not show any reactive band because almost the whole pmfA gene had been deleted. Similarly, DNA was digested separately with SspI and SalI, and probed with the Km R cassette. Pr2921 did not show reactive bands, as expected. P1 and P2 showed two bands when digested with SspI, since the Km R gene has an internal SspI site. The SalI digestion of P1 and P2 showed a single 1?3 kb band that corresponded to the released Km R cassette. One of the mutants, P2, was chosen for further experiments.
Phenotypic analysis of wild-type Pr2921 and the mutant strain P2
Typical P. mirabilis swarming motility was exhibited by both strains when grown on LB agar plates. No differences in net growth rate were observed between parental and mutant strains when growth curves were constructed, showing generation times of 28?3 and 28?1 min, respectively. Both strains were urease-positive, agglutinated fresh equine and ovine erythrocytes, and exhibited similar haemolytic activities. After the wild-type and mutant strains were co-cultured for 7 days in LB broth, and viable plate counts on LB agar and LB supplemented with kanamycin were performed, numbers of recovered c.f.u. were similar for both strains, showing that the mutant strain was not out-competed by the wild-type strain.
The ability of strains Pr2921 and P2 to synthesize PmfA was assessed by SDS-PAGE and Western blotting. For Western blotting, we used the anti-PmfA serum produced after successful expression and purification of the recombinant protein (Fig. 1A) and rabbit immunization. Total protein extracts from cultures of Pr2921 grown in LB broth (48 h at 37 u C) showed a clear band of about 20 kDa corresponding to PmfA when analysed by Western blot. Total protein extracts of strain P2 grown under the same conditions exhibited no reactive bands under the same conditions (Fig. 1B) , confirming that P2 is deficient in PmfA expression as expected. As a further control we were able to detect PmfA expression from a P. mirabilis mutant deleted for mrpA, a gene required for expression of the unrelated MrpA fimbriae. Fig. 1 . SDS-PAGE analysis of recombinant PmfA expression and Western blot analysis of whole-cell proteins to detect PmfA expression by the wild-type and mutant strains. (A) Expression and purification of recombinant PmfA using the pET-21a(+) system. Lanes: 1, purified PmfA; 2, PmfA expression strain after induction; 3, PmfA expression strain before induction; 4, marker proteins (Bio-Rad). Marker proteins: phosphorylase b (97 kDa), serum albumin (66 kDa), ovalbumin (45 kDa), carbonic anhydrase (31 kDa), trypsin inhibitor (21?5 kDa). The arrow indicates PmfA. (B) Western blot analysis of whole-cell proteins to detect PmfA expression by the wild-type Pr2921 and the mutant strain P2 using a polyclonal rabbit anti-PmfA serum. Lanes: 1, wild-type Pr2921; 2, pmfA mutant P2; 3, mrpA mutant MSD2. The arrow indicates PmfA.
Bacterial adherence to uroepithelial cells
The wild-type strain Pr2921 and the mutant strain P2 were tested for their capacity to bind cultured uroepithelial cells. The number of P2 bacteria that adhered to T24/83 cells was significantly lower than the number of Pr2921 bacteria per uroepithelial cell after 1 h incubation (1?7±0?05 and 3?8±0?09, respectively, P=0?006). When bacterial adherence to uroepithelial cells from fresh urine of healthy female volunteers was tested, the number of adhered P2 bacteria was also significantly lower than the number of attached wild-type Pr2921 bacteria (6?9±5?9 and 42?4±37?1, respectively, P=4610
25
).
PmfA expression by P. mirabilis strains of different origins
To evaluate PmfA expression by non-uropathogenic P. mirabilis isolates, strains from several clinical and non-clinical sources were examined by Western blot. All strains showed a reactive band that corresponded to PmfA (Fig. 2) .
Infection studies
The role of PMF in colonization and virulence in UTIs was assessed using two models, a co-challenge ascending UTI model and a haematogenous UTI model, both in CD-1 mice.
For the co-challenge experiment, bacteria were recovered from bladder and kidneys 7 days after transurethral challenge and were enumerated on normal non-swarming 2 % (w/v) LB agar (lacking NaCl), on which Pr2921 and P2 could grow, and on non-swarming 2 % (w/v) LB agar plates containing kanamycin (40 mg ml 21 ), on which only the mutant strain could grow. The number of viable bacteria counted from bladder and kidneys showed that the mutant strain was significantly out-competed by the wildtype strain in colonizing the kidneys (P=0?0054) and the bladders (P=0?0111) (Fig. 3) .
When the intravenous infection model was used, the infectivity was significantly lower in mice challenged with the isogenic mutant strain than in mice challenged with the parental strain (P=0?0015). Almost every mouse inoculated with the wild-type was infected (16/17, 94 %) but just nine out of 20 mice inoculated with the mutant were infected (45 %).
DISCUSSION
Fimbriae have been demonstrated as important virulence factors that play a role in P. mirabilis-associated UTIs. Several studies indicate that MR/P fimbriae are important virulence attributes related to the colonization of the urinary tract by P. mirabilis (Zunino et al., 2001; Bahrani et al., 1994) . However, we reported that ambient-temperature Fig. 2 . Western blot analysis of whole-cell proteins to detect PmfA fimbriae expression from different strains of P. mirabilis using polyclonal rabbit anti-PmfA serum. (A) Lane: 1, HE1; 2, SEC1; 3, SAF1; 4, OPS; 5, pmfA mutant P2; 6, BZ3; 7, BZ2; 8, BZ1. The arrow indicates PmfA. (B) Lanes: 1, EMI2; 2, EMI1; 3, XT1; 4, XT2; 5, Pr2921; 6, pmfA mutant P2; 7, 4149; 8, Pr6515; 9, Pr783. The arrow indicates PmfA. Fig. 3 . Virulence of wild-type Pr2921 and pmfA mutant P2 in the co-infection ascending UTI model in mice. The median (horizontal bar) is indicated for each group. The medians of wild-type Pr2921 and pmfA mutant P2 recovered from the kidneys were 6?25 and 2?83 log 10 c.f.u., respectively. The medians of wild-type Pr2921 and pmfA mutant P2 recovered from the bladders were 6?66 and 3?81 log 10 c.f.u., respectively. The limit of detection was 10 2 c.f.u. per kidney or bladder. P values were determined by the Mann-Whitney non-parametric test.
fimbriae (ATF) do not play a role in P. mirabilis-associated UTIs (Zunino et al., 2000) , a finding that was also confirmed by .
There is only one report related to the potential role of PMF in P. mirabilis-associated UTIs . In that study, the authors constructed a pmfA isogenic mutant that was tested only in an independent challenge using the ascending UTI model in the mouse. They concluded that PMF play a role in colonization of the bladder but not in colonization of kidney tissue, since they could not detect a significant difference in bacterial numbers recovered from the kidneys between mice infected with the wild-type strain and those infected with the PMF mutant .
In the present work, we generated a pmfA allelic replacement isogenic mutant that was used in different in vivo and in vitro assays. We also determined the expression of PMF by several clinical and non-clinical isolates of P. mirabilis.
The process of mutating pmfA did not apparently affect other bacterial virulence attributes, including growth rate, swimming or swarming motility, urease and haemolysin production or haemagglutination. Fitness of the mutant was also confirmed when the parental and mutant strains were recovered in similar numbers after co-culturing in LB broth and subsequent plating on LB agar and LB agar supplemented with kanamycin.
The insertion of a Km R gene for mutagenesis allowed us to perform a co-challenge ascending UTI assay. We had previously used this approach to evaluate the role of ATF and MR/P fimbriae in P. mirabilis-associated UTIs (Zunino et al., 2000 (Zunino et al., , 2001 . This assay allowed us to assess the ability of the wild-type strain to out-compete the mutant in the initial stages of UTI. Using this infection model we established that the mutant was unable to compete with the wild-type not only in the bladder but also in the kidneys of the infected mice.
Although UTIs are ascending rather than haematogenous, the haematogenous UTI model can provide useful data about colonization of the kidneys. When the mutant (P2) was used in this model, it was found to be significantly decreased in infectivity. This suggests that PMF play a role in localization of uropathogenic P. mirabilis to the kidneys. In both models, infectivity of the mutant was clearly impaired, including its ability to colonize the kidneys. These results are in disagreement with those reported by , since these authors suggested that PMF are not related to kidney colonization.
Mutant strain P2 was used in two different in vitro bacterial adherence assays. In the first model, we used transformed, cultured T24/83 cells. We had used this technique in previous work to evaluate the role of MR/P in P. mirabilis adherence to uroepithelial cells (Zunino et al., 2001 ). When we assessed the adherent ability of Pr2921 and P2 to T24/83 cells, we noted a significant decrease in the number of adherent pmfA mutant bacteria compared to the number of adhered wild-type bacteria. We also performed another bacterial adherence test using exfoliated uroepithelial cells isolated from fresh urine, initially used by Wray et al. (1986) to assess adherence properties of P. mirabilis uroepithelial cell adhesin fimbriae, and a significant decrease in attached mutant bacteria was also noted. These results are also different from those obtained by , since these authors could not detect significant differences between adherent wild-type and mutant bacteria to uroepithelial cells. Our in vitro adherence assays to both transformed and desquamated uroepithelial cells strongly suggest that PMF play a role in bacterial adherence and colonization of the urinary tract at least during the initial stages of infection. It is interesting to note that different cell types were used by both groups.
The expression of PmfA was assessed in numerous clinical and non-clinical strains using a rabbit polyclonal antiserum for Western blotting. It is interesting to note that all strains of different origins expressed PmfA. This result confirms that P. mirabilis is a very homogeneous species and could also indicate that P. mirabilis strains cannot be separated into clonal pathogenic groups and that the distribution of virulence factors between strains of different origins reflects the opportunistic nature of the organism. We are currently assessing the distribution of other virulence factors among numerous P. mirabilis strains from different clinical and non-clinical sources. As a complementary result, we observed that PmfA expression was also qualitatively detected in a total protein extract of the P. mirabilis mutant MSD2, generated in a previous study (Zunino et al., 2001) . This may suggest that MR/P fimbriae and PMF expression are unrelated, since PMF biosynthesis was not apparently affected by the MR/P mutation.
It is interesting to note that, as in our previous study using a mutant lacking MR/P, in vitro bacterial adherence of the pmfA mutant to uroepithelial cells was not totally suppressed. Moreover, infectivity was not abolished when mice were challenged with either mrpA or pmfA mutants. These findings suggest that redundancy of effects between different fimbriae is very likely.
